Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of

Ugo Fedeli1, Claudio Barbiellini Amidei1, Francesco Avossa1

  • 1Epidemiological Department, Azienda Zero, Veneto Region, Italy.

PubMed
Abstract

Insights

Infections significantly increase mortality risk for multiple sclerosis (MS) patients, particularly influenza and pneumonia. While COVID-19 deaths didn't differ, MS-related deaths peaked during pandemic waves, highlighting infection management needs.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Multiple sclerosis (MS) patients face higher infection-related mortality than the general population.
  • Limited data exists on the specific risks of COVID-19 and other infections contributing to MS mortality.

Purpose of the Study:

  • To investigate the association between specific infections and mortality in individuals with multiple sclerosis (MS).
  • To compare infection-related death rates in MS patients before and during the COVID-19 pandemic.

Main Methods:

  • Analysis of mortality records (2010-2021) from the Veneto region, Italy.
  • Comparison of infection mentions on death certificates for MS versus non-MS cases.
  • Logistic regression to estimate odds ratios for infection-related deaths in MS patients.
  • Comparison of MS-related deaths during pre-pandemic (2010-2019) and pandemic (2020-2021) periods.

Main Results:

  • Infections were mentioned in 18.4% of MS-related deaths versus 11.0% of non-MS deaths.
  • Influenza and pneumonia showed significantly higher odds (OR 2.72) in MS-related deaths.
  • Urinary tract infections were more frequent in MS men (OR 8.16) than women (OR 3.03).
  • Aspiration pneumonia, skin infections, and sepsis were also linked to MS mortality.
  • COVID-19 as a cause of death did not significantly differ between MS and non-MS groups.
  • MS-related deaths showed peaks during pandemic waves compared to pre-pandemic years.

Conclusions:

  • Infections remain a critical factor contributing to mortality in multiple sclerosis (MS) patients.
  • Enhanced strategies for infection prevention and management are crucial for improving outcomes in MS.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.0K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.3K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
281
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9